Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Theratechnologies, Inc. is a biopharmaceutical company that specializes in therapeutic peptide products, with an emphasis on growth-hormone releasing factor, or GRF, peptides.
Price: $0.55 | Change: $0.00 | %Change: 0.00%
Volume: 6,278 | Day High/Low: 0.55/0.54 | 52 Week High/Low: 0.65/0.325
View modes: 
0 stars

RE:Weakening canadian dollar

That BOC interest rate cut should help our cause The loonie is now below 81 cents U.S.  rate and reply
0 stars

Weakening canadian dollar

very positive for TH since most costs are in Canadian dollars and all revenues are in US dollars We don't know what the current revenues are but we know that they are less than future potential so we...read more
0 stars

RE:RE:nice %increase today but on low volume

Maybe the uptick is reflective of the bigger picture...surely by now the sales trend is known by some  rate and reply
0 stars

RE:nice %increase today but on low volume

Of course it is nice to see an uptick, but I am looking at the bigger picture.  We probably have about 6 weeks until we'll see what the Egrifta sales numbers and the number of patients on Egrifta.  I...read more
1 star

RE:nice %increase today but on low volume

1 cad in short time ?? What other stocks in CAD do you follow ?? Once there was a good market in CAD biotech , but now ......................?????!!!!! canadapiet  rate and reply
0 stars

nice %increase today but on low volume

need more volume and many more updays like today  rate and reply
0 stars

RE:RE:RE:RE:RE:Fidelity

Fidelity is at it again today!!!  rate and reply
3 stars

2015

2015 should see EBITDA of at least 5 million and this will all be tax free considering the loss carry forward.  If sales can accelerate with better branding and messaging, the upside is enormous.   It...read more
0 stars

RE:RE:RE:RE:Fidelity

I share your optimism. Sales during the fiscal fourth quarter of 2014, however, are not the issue as sales were just restarting from a complete stop. The number to focus on is the number of patients...read more
0 stars

RE:RE:RE:Fidelity

6000 shares traded at .405 65000 share traded in THERF @ about .43 Maybe sales won't be stellar in this past quarter. Apparently all patients have been sent a letter notifying them of Egrifta...read more
0 stars

RE:RE:Fidelity

141k shares traded in THERF also...  rate and reply
0 stars

RE:Fidelity

Fidelity doing most of the buying again today,,,..  rate and reply
0 stars

Sorry for multiple post

My bad!!!  rate and reply
0 stars

Fidelity

Did some serious buying at end of day We need many more trading days like today Maybe finally some positive news  rate and reply
0 stars

Fidelity

Did some serious buying at end of day We need many more trading days like today Maybe finally some positive news  rate and reply
0 stars

Fidelity

Did some serious buying at end of day We need many more trading days like today Maybe finally some positive news  rate and reply
0 stars

RE:Pooya Hemami used to be the analyst at Desjardins covering

original source How to Bargain Hunt for Hot Biotechs: Edison's Pooya Hemami Source: Peter Byrne of The Life Sciences Report  (10/15/14) Every business day, Edison Investment Research Analyst Pooya...read more
0 stars

After six weeks of selling Egrifta again

The PPS has gone from 59 cents to 37.5 cents in six weeks.  I hope it is not an indication of how well the selling is going.  rate and reply
5 stars

RE:Euro Pacific Raise Price Target to $1 and rating to Spec Buy

Same guy who had a 12$ target price for TH while he was at Versant Partners couple years ago Lolllllll This company has the worst management team around...and by far! Never again...  rate and reply
5 stars

Euro Pacific Raise Price Target to $1 and rating to Spec Buy

Euro Pacific analyst Doug Loe has come out with a new report that raises the price target to $1 and the rating to speculative buy.  rate and reply